investingreview.org logo
Evite fraudes, obtenha os fatos e encontre o melhor
Nothings Found.

Boltwood Capital Management's Q4 2022 vs. Q1 2023: A Look at 13F Holdings Comparison

Ava Hoppe | 27 April, 2023

Boltwood Capital Management, an investment management firm with a fundamental, research-driven approach, recently released its Form 13F filing for the fourth quarter of 2022 and first quarter of 2023. Many investors use this filing to gain insight into what institutional investors are buying and selling. In this blog post, we will explore the changes in Boltwood Capital Management's holdings from Q4 2022 to Q1 2023.

But before we delve into the data, what is Form 13F?

Form 13F is a quarterly report required by the SEC of institutional investment managers that manage more than $100 million in assets. It requires them to disclose their equity holdings within 45 days following the end of each calendar quarter. With this information, other investors can get a glimpse into what stocks these institutional investors are buying and selling.

Now, let's dive into the data. Boltwood Capital Management's Q4 2022 Form 13F shows that their total 13F holdings were valued at $186,381,000, while their holdings in Q1 2023 were valued at $200,499,000. This indicates an increase of approximately 7.6%.

In terms of individual holdings, Boltwood Capital Management made significant changes and adjustments to its portfolio. Here are some of the key changes:

The largest percentage increase was in NVIDIA Corporation (NVDA). Boltwood Capital increased its holdings in the technology company by 100.1% from 5,898 shares in Q4 2022 to 6,210 shares in Q1 2023. The value of the holdings increased from $861,000 to $1,724,000.

Similarly, Salesforce Inc. (CRM) saw a 50% increase in Boltwood's holdings from 10,571 to 10,526 shares. The value of these holdings increased from $1,401,000 to $2,102,000.

On the other hand, Pfizer (PFE) saw a significant decrease in their holding, as the number of shares fell from 62,823 to 63,768 shares. The value of these holdings decreased from $3,219,000 to $2,601,000, indicating a 19.2% drop.

Chevron Corporation (CVX) also saw a decrease in holdings, with the number of shares falling from 23,700 to 23,944 shares, and the value of these holdings dropping from $4,253,000 to $3,906,000 indicating an 8.2% drop.

Furthermore, Boltwood Capital Management sold all its shares in Vanguard International Equity Index Fund (VWO) from Q4 2022 and purchased 27,345 shares in Q1 2023, which were valued at $1,104,000. This move indicates the clearest outright sale during the period covered by the 13F.

These are just a few examples of the changes that Boltwood Capital Management made to its portfolio during the period in question. Overall, the data shows that Boltwood Capital Management made various adjustments and changes to its holdings, with some significant increases and decreases.

In conclusion, Boltwood Capital Management's Q4 2022 vs. Q1 2023 13F Holdings Comparison reveals some interesting insights into the firm's investment strategy. By analyzing the changes in the firm's holdings, we can see where they placed their bets and where they may see potential. It's important to remember, however, that the 13F only provides a partial picture of an institutional investor's holdings and investment strategy. It is critical to do additional research before making any investment decisions.

Muitas pessoas foram queimadas por fraudes e esquemas de Ponzi. Por isso, criamos este site para ajudar você, o potencial investidor, a obter os fatos, encontrar o melhor e evitar fraudes e esquemas Ponzi.

Todas as informações fornecidas neste site são fornecidas sem garantia e apenas para fins informativos.
InvestingReview.org não fornece consultoria de investimento. InvestingReview.org não é um consultor de investimentos e não é endossado ou afiliado a nenhuma agência reguladora dos EUA ou de fora dos EUA.


Empresas Pesquisadas Recentemente

Observação: os dados de pesquisa são acumulados por terceiros e atualizados uma vez por dia.

Copyright © 2023 by InvestingReview.org / Todos os direitos reservados.